6 Paid Clinical Research Studies in New Hyde Park, New York

Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT

Phase I-II studying post transplant cyclophosphamide, bortezomib and sitagliptin for GvHD prevention in allogeneic HSCT. Adults with hematologic malignancies undergoing an RIC allo

📍 Northwell Health — New Hyde Park, New York

💵 Patients will receive RIC with fludarabine, busulfan (rATG in unrelated donor grafts) in preparation for allogeneic hema

Virtual Personalized Exercise Program for Lung Cancer Patients

This is a prospective study providing lung cancer subjects at R.J. Zuckerberg Cancer Center with a customized exercise program provided by Salaso, with the goal of improving functi

📍 Northwell Health — New Hyde Park, New York

Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

A Phase II randomized, placebo controlled study design of anakinra (Kineret) in corticosteroid-resistant or intolerant Meniere's disease (CR-MD)and corticosteroid-resistant or into

📍 Northwell Health, Hearing& Speech Center — New Hyde Park, New York

💵 After day 42, a second placebo-controlled period will begin for an additional 42 days (all patients will receive anakinr

Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices

The purpose of this study is to see if a randomized controlled trial of ovarian vein and pelvic vein embolization versus venography alone could determine outcomes for women with ch

📍 Northwell Health Physician Partners Vascular Surgery — New Hyde Park, New York

Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Devices

Transcutaneous auricular vagus nerve stimulation (taVNS) has become a therapy of interest for treating chronic immune-medicated illnesses in adults and children. Vagustim™ taVNS de

📍 Cohen Children's Medical Center, Pediatric Nephrology — New Hyde Park, New York

Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

This is a phase I-II clinical trial. Adult subjects with hematological malignancies undergoing allogeneic HSCT from an HLA matched sibling or ≥7 out of 8 allele level HLA matched u

📍 Northwell Health — New Hyde Park, New York

💵 Subjects will receive a standard of care conditioning regimen.